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Sto assess minimal stent diameter and area (MSD and MSA). Stent expansion was
deﬁned as MSD (or MSA) divided by the values predicted by the manufacturers'
compliance charts. Patients were divided into 4 groups according to the median values
of arc and area of calcium.
Results: Mean stent expansion was 73.3  8.7% for MSD and 65.2  12.0% for
MSA. Stent expansion deﬁned by MSD was signiﬁcantly different among the groups
(p ¼ 0.02) (Figure). Similar trend was observed for stent expansion deﬁned by MSA
(p ¼ 0.16).Conclusions: Stent expansion of the 2nd generation DESs may be predicted by the
amount of target lesion calciﬁcation assessed by OCT.
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Background: To examine the endothelial shear stress (ESS) patterns, the neointimal
distribution and the relation between ESS and neointimal thickness (NT) in models
derived from the integration of frequency domain optical coherence tomographic (FD-
OCT) and coronary angiographic data and compare these estimations with those
computed in the traditional reconstructions obtained by the fusion of intravascular
ultrasound (IVUS) and coronary angiography.
Methods: Six segments implanted with an Absorb Bioresorbable Vascular Scaffold
(Absorb BVS) that were investigated with FD-OCT and IVUS examination at baseline
and 6 or 12 months follow-up were included. The IVUS and OCT data acquired at
follow-up were fused separately with the angiographic data to reconstruct the luminal
surface at baseline and follow-up. Blood ﬂow simulation was performed on the
baseline IVUS-based and OCT-based models and computational ﬂuid dynamics
techniques were implemented to assess the ESS and the association between the ESS
and the measured NT at follow-up.
Results: The IVUS-based models appeared to underestimate the neointima
tissue (0.670.59 mm3 vs. 15.145.63 mm3, P¼0.001) compared to the FD-
OCT-based reconstructions. Flow recirculation zones were detected in the FD-
OCT-based reconstructions and the ESS values were lower compared to the
IVUS-based models (1.290.66 Pa vs. 1.870.66 Pa, P¼0.030). These differ-
ences should be attributed to the poor resolution of IVUS that did not allow
visualization of the protruded struts. A statistically signiﬁcant inverse correlation
was noted between the logarithmic ESS at baseline and the NT at follow-up in all
the FD-OCT-based models which was higher than the correlation reported in 5 of
the 6 IVUS-derived models (mean correlation coefﬁcient: -0.520.19 vs.
-0.100.04, P¼0.028).
Conclusions: It appears that the models derived by the fusion of IVUS and coronary
angiography cannot provide enough detail and are incapable of assessing the micro-
environment and its effect on neointima formation following an Absorb BVS
implantation. FD-OCT reconstruction appears superior to IVUS-based reconstruc-
tions and it should be preferred for studying the effect of ESS on neointimal
proliferation.B170 JACC Vol 62/18/Suppl B j October 27–NoveTCT-564
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Background: The aim of this study is to examine the implications of the local
endothelial shear stress (ESS) on neointimal proliferation following an Absorb Bio-
resorbable Vascular Scaffold (BVS) implantation.
Methods: Twelve patients who had an Absorb BVS implantation in a stenotic,
relatively straight arterial segment and who were investigated with serial optical
coherence tomographic examination at baseline and 1 year follow-up were included in
the current analysis. The optical coherence tomographic data acquired at follow-up
were used to reconstruct the treated segment. Blood ﬂow simulation was performed on
the luminal surface at baseline deﬁned by the Absorb BVS struts and the estimated
ESS was related to the neointima thickness measured at 1year follow-up.
Results: The protruded struts appeared to affect the ESS patterns. Low ESS and recircu-
lation zoneswere noted between the struts areas and highESS zones on the top of the struts.
At baseline, , 61% of the measured ESS were <1 Pa. At follow-up, the mean neointima
thickness was 11345 mmwhile the percentage area obstruction was 13.16.6%. Aweak
but statistically signiﬁcant inverse correlation was noted between baseline ESS and neo-
intima thickness at 1year follow-up in all studied segments (correlation coefﬁcient range:
-0.110 to -0.620). Mixed linear regression analysis between baseline ESS and neointima
thickness at follow-up yielded a slope of -29 mm/Pa and a y-intercept of 142 mm.
Conclusions: The hemodynamic micro-environment appears to regulate neointimal
response following an Absorb BVS implantation. These ﬁndings underline the role of
the ESS patterns on vessel wall healing and should be taken into consideration in the
design of bioresorbable devices.
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Background: Biodegradable stent coatings are hoped to improve the vessel wall
healing. ALEX is a new generation, biodegradable polymer-coated, sirolimus-eluting,
cobalt-chromium coronary stent system.
Methods: A prospective, single arm, multi-centre registry enrolled 60 patients with de
novo native coronary lesions treated with ALEX stent and examined the outcomes by
quantitative coronary analysis (QCA) and optical coherence tomography (OCT) at
multiple timepoints (3 subgroups of 20 patients each at 3, 6 and 12 months) to capture
the time course of vessel healing. Stent strut coverage, stent apposition and neointimal
proliferation were assessed by OCT. Safety endpoint was the composite of death,
myocardial infarction, target lesion re-intervention (TLR) and stent thrombosis (ST) at
30 days and 12 month follow-up.
Results: At baseline, reference vessel diameter was 2.85 (IQR 2.45, 3.17) mm, lesion
length was 12.00 (IQR 9.67,14.58), minimal lumen diameter was 1.020.40 mm and
percent diameter stenosis (%DS) was 6511.5 by QCA. We have treated 31% of
lesions type A/B1 and 69% of lesions type B2/C. Median stent diameter was 3.0 (IQR
2.75, 3.50) mm, stent length was 15 (IQR 12; 20) mm. Procedural device success rate
was 98,7% with post-procedural %DS 6.0 (IQR 2.0; 8.5). QCA analysis revealed
median late lumen loss (mm) 0.035 (IQR -0.047, 0.01) at 3 months, 0.17 (IQR -0.01,
0.32) at 6 months, and 0.14 (IQR 0.07, 0.42) at 12 months. The OCT analysis pre-
sented full strut coverage in 96% at 3 months, in 98% at 6 months, and 100% at 12
months. The rate of uncovered stent struts per section (RUST) >0.3 was 3.15% at 3
months, 1.74% at 6 months, and 0% at 12 months of follow-up, and the malapposition
rate was 0.13%, 0.03% and 0.02%, respectively. There was one death (1,7%), one
TLR (1,7%) and no deﬁnite ST at 12th months of follow-up.
Conclusions: Biodegradable polymer-coated, sirolimus-eluting ALEX stent appears
to feature very favourable proﬁle of arterial wall healing already at 3 months postmber 1, 2013 j TCT Abstracts/POSTER/Intravascular Imaging and PCI
